← Oncology Approval Tracker

FDA DECISION ·

Vidaza

azacitidine · Celgene / Bristol Myers Squibb

FDA approvalNew or expanded indicationJuvenile myelomonocytic leukemia
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Newly diagnosed juvenile myelomonocytic leukemia in pediatric patients at least one month old.

LAMPGEN ANALYSIS

Why it matters

The action adds a treatment for a rare childhood leukemia.

What research teams should watch

Confirm pediatric diagnostic criteria and coordinate response assessment with the transplant team.

PRIMARY RECORDS

Sources